Anti-CA19-9 Antibody (Coating) SPECIFICATION SHEET Catalog #: L1C00901 Lot #: C081024 Description: MAb to Cancer Antigen CA19-9 Monoclonal Antibody to Human Cancer Antigen CA19-9 (Gastrointestinal Cancer) Specificity: Reacts specifically with Sialyl Lewisa containing glycolipids, without detectable reactivity with Lewisª, Lewisb or structurally related substances as determined by solid-phase binding assays against glycolipid antigens. Shows minimal cross-reactivity (<1%) with Sialyl Lacto-N-tetraosylceramide. Clone: 1116-NS-19-9 Host Animal: Mouse. Hybridization of NS-1 myeloma Isotype: IgG1 cells with spleen cells from Balb/c mice. Source: mouse ascites Immunogen: Human colorectal adenocarcinoma cell-line SW1116 Format: Purified, Liquid Purification: Protein A chromatography Concentration: 4.55mg/ml (OD280nm, E0.1% = 1.414) Affinity Constant: 5x 10-9 mol/l Buffer: 0.01M PBS PH7.4 Preservative: None Applications: Capture antibody in serological assays for the research of CA19-9. Immunohistochemistry on frozen or paraffin sections for the detection of Sialyl Lewisa. Immunochemical detection of Sialyl Lewisa determinant in mucins and glycolipids. Each laboratory should determine an optimum working titer for use in its particular application. Other applications have not been tested but use in such assays should not necessarily be excluded. Recommended antibody pair for immunoassay: Capture Detection 1116-NS-19-9 1116-NS-19-9 QC Information: IgG >90% of total peak area (Superdex 200 gel chromatography on ÄktaFPLC). Storage: Short-term (up to 2 months) store at <-20°C. Long term (>2 months) store at <–40°C. FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC PROCEDURES.